Home › Asset managers › Compare 2023-2024 › Charles Schwab vs Jackson National
Charles Schwab 2023-2024 · Jackson National 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 4,578 | 3,845 | 255 | 478 | 93.8% | 90.4% |
| Board proposals | 3,667 | 3,217 | 196 | 254 | 94.3% | 91.7% |
| E&S shareholder proposals | 221 | 142 | 5 | 74 | 96.6% | 88.8% |
| Other items | 690 | 486 | 54 | 150 | 90.0% | 84.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
255 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | Jackson National |
|---|---|---|---|---|---|---|
| COMSCORE INC. | June 12, 2024 | The approval of an amendment to the Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of the company's common stock available for grant by 900,000 Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| CONAGRA BRANDS INC. | September 14, 2023 | Advisory vote to approve named executive officer compensation Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 7 funds |
| CORVUS PHARMACEUTICALS INC. | June 13, 2024 | To elect one Class II Director with term to expire at the 2027 annual meeting of stockholders: Scott W. Morrison Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| COSTAMARE INC. | October 3, 2023 | Election of Class I Director to hold office for a three-year term expiring at the 2026 annual meeting: Konstantinos Zacharatos Director Elections |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CRINETICS PHARMACEUTICALS INC. | June 7, 2024 | To elect two directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Camille Bedrosian, M.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 2 funds |
| CS DISCO INC. | June 13, 2024 | To elect our three nominees as Class III directors, each to hold office until our Annual Meeting of Stockholders in 2027: Susan L. Blount Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| CUE BIOPHARMA INC. | June 5, 2024 | The approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| CUSTOM TRUCK ONE SOURCE INC. | June 13, 2024 | To amend the Custom Truck One Source, Inc. Amended and Restated 2019 Omnibus Incentive Plan to increase the number of shares available for the grant of awards from 14,650,000 shares to 20,650,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| DESIGN THERAPEUTICS INC. | June 13, 2024 | To elect the one nominee for Class III director named herein to serve for a three-year term until the 2027 Annual Meeting of Stockholders: Pratik Shah, Ph.D. Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| DRIVEN BRANDS HOLDINGS INC. | May 9, 2024 | Approval of the Amended and Restated Driven Brands Holdings Inc. 2021 Omnibus Incentive Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| DULUTH HOLDINGS INC. | May 23, 2024 | To approve the 2024 Equity Incentive Plan of Duluth Holdings Inc. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| EASTMAN KODAK CO. | May 15, 2024 | Approval of the Second Amendment to the Amended and Restated 2013 Omnibus Incentive Plan Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| EGAIN CORP. | December 5, 2023 | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| EHEALTH INC. | June 12, 2024 | Approval, on an advisory basis, of the compensation of the Named Executive Officers of eHealth, Inc. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ENANTA PHARMACEUTICALS INC. | March 6, 2024 | To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| ENCORE WIRE CORP. | May 7, 2024 | BOARD PROPOSAL TO APPROVE, IN A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| ENTERPRISE BANCORP INC. | May 7, 2024 | Election of the following five directors of the Company, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified, or until their earlier resignation, death or removal from office: Gino J. Baroni Director Elections |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ENTRAVISION COMMUNICATIONS CORP. | May 30, 2024 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| ESCALADE INC. | May 8, 2024 | To approve, by non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ESSA BANCORP INC. | March 7, 2024 | The consideration of an advisory, non-binding resolution with respect to the executive compensation described in the Proxy Statement. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| EXTREME NETWORKS INC. | November 8, 2023 | Approve an amendment and restatement of the Extreme Networks, Inc. 2013 Equity Incentive plan to, among other things, add 5,000,000 shares of our common stock to those reserved for issuance under the plan; and Compensation |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| EYEPOINT PHARMACEUTICALS INC. | June 20, 2024 | To approve an amendment to the EyePoint Pharmaceuticals, Inc. 2023 Long-Term Incentive Plan to (i) increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares and (ii) increase the individual non-employee director compensation limit contained therein to $850,000 for ongoing directors in any calendar year and $1,100,000 for new directors in any calendar year. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| F&G ANNUITIES & LIFE INC. | July 12, 2023 | Approval of a non-binding advisory resolution on the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 1 fund |
| FARMER BROS. CO. | January 24, 2024 | To hold an advisory (non-binding) vote to approve the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| FATE THERAPEUTICS INC. | June 7, 2024 | To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. Compensation |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| FATE THERAPEUTICS INC. | June 7, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| FERROGLOBE PLC | June 18, 2024 | THAT, for the purposes of section 694 of the Companies Act, the terms of the buyback contract to be entered into between the Company and any or all of J.P. Morgan Securities LLC, BMO Capital Markets Corp. and Santander US Capital Markets LLC, respectively are approved and the Company be authorized to undertake off-market purchases (within the meaning of section 693(2) of the Companies Act) of its ordinary shares of US $0.01 pursuant to such contracts. Capital Structure |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| FIRST OF LONG ISLAND CORP. | April 16, 2024 | Non-binding, advisory vote to approve the Corporation's executive compensation as discussed in the proxy statement; Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| FIRST WESTERN FINANCIAL INC. | June 5, 2024 | Advisory, non-binding vote to approve the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| FRANKLIN BSP REALTY TRUST INC. | May 29, 2024 | ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| FVCBANKCORP INC. | May 15, 2024 | To Approve the following (non-binding) resolution: Resolved, that the shareholders of FVCBankcorp, Inc., approve the compensation of the named executive of the named executive officers as disclosed in the proxy statement pursuant to the rules of the Securities and Exchange Commission Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| GAMBLING.COM GROUP LTD. | May 15, 2024 | To re-appoint Michael Quartieri as a Class III director of the company. Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| GLAUKOS CORP. | May 30, 2024 | Approval of the Glaukos Corporation Amended and Restated 2015 Omnibus Incentive Compensation Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 7 funds |
| GLOBAL NET LEASE INC. | May 23, 2024 | Approval, on an advisory, non-binding basis, of the compensation paid to the Company's named executive officers identified in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 2 funds |
| GRAPHITE BIO INC. | March 14, 2024 | To approve the 2024 ESPP (as defined in the related proxy statement/prospectus). Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| GRAPHITE BIO INC. | March 14, 2024 | To approve the 2024 Plan (as defined in the related proxy statement/prospectus). Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| GREENLIGHT CAPITAL RE LTD. | July 25, 2023 | To consider and vote upon a proposal to approve and adopt the 2023 Omnibus Incentive Plan; Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| GSI TECHNOLOGY INC. | August 24, 2023 | To vote on an advisory (non-binding) resolution regarding the fiscal 2023 compensation of the executive officers named in the Summary Compensation Table included in the proxy statement for the annual meeting. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| GUARANTY BANCSHARES INC. | May 15, 2024 | Non-binding advisory vote on the compensation of the Company's named executive officers (Say-on-Pay Vote). Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| HALLMARK FINANCIAL SERVICES INC. | October 5, 2023 | ADVISORY VOTE ON RESOLUTION TO APPROVE EXECUTIVE COMPENSATION. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| HALLMARK FINANCIAL SERVICES INC. | October 5, 2023 | ELECTION OF DIRECTOR: Mark E. Pape Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| HEIDRICK & STRUGGLES INTERNATIONAL INC. | May 23, 2024 | Approval of the Fifth Amended and Restated Heidrick & Struggles 2012 GlobalShare Program. Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| HOVNANIAN ENTERPRISES INC. | March 21, 2024 | Approval of the Third Amended and Restated 2020 Hovnanian Enterprises, Inc. Stock Incentive Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| HUDSON PACIFIC PROPERTIES INC. | May 15, 2024 | The advisory approval of the Company's executive compensation for the fiscal year ended December 31, 2023, as more fully disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| IDEAYA BIOSCIENCES INC. | May 31, 2024 | To elect two Class II directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected: Terry J. Rosen, Ph.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 2 funds |
| INARI MEDICAL INC. | April 24, 2024 | To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rebecca Chambers Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 5 funds |
| INDIE SEMICONDUCTOR INC. | June 13, 2024 | To approve an amendment to the 2021 Omnibus Equity Incentive Plan to increase the number of shares of Class A Common Stock reserved for issuance thereunder by 7,000,000 shares. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| INTEVAC INC. | May 15, 2024 | Proposal to approve an amendment to the Intevac 2020 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 900,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| INTUITIVE SURGICAL INC. | April 25, 2024 | The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. Compensation |
Board | For | AGAINST 15 funds |
FOR 17 funds |
| INVESTAR HOLDING CORP. | May 15, 2024 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| IROBOT CORP. | May 23, 2024 | Approve an amendment to the iRobot Corporation 2018 Stock Option and Incentive Plan, as amended (the "2018 Plan"), to increase the maximum number of shares reserved and issuable under the 2018 Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| IROBOT CORP. | May 23, 2024 | Approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| JETBLUE AIRWAYS CORP. | May 17, 2024 | To approve an amendment to the JetBlue Airways Corporation 2020 Omnibus Equity Incentive Plan to increase the number of shares of common stock authorized for issuance Compensation |
Board | For | FOR 7 funds |
AGAINST 6 funds |
| KALVISTA PHARMACEUTICALS INC. | September 26, 2023 | The election of two Class II directors to hold office until the earliest of our 2026 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor: PATRICK TREANOR Director Elections |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| KANZHUN LIMITED | June 28, 2024 | To re-elect Mr. Peng Zhao as an executive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to extend the general mandate granted to the Directors to issue, allot, and deal with additional Shares in the share capital of the Company by the aggregate number of the Shares and| |or Shares underlying the ADSs repurchased by the Company. Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to grant a general mandate to the Directors to issue, allot, and deal with additional Class A ordinary shares of the Company not exceeding 20% of the total number of issued Shares (excluding treasury shares) of the Company as of the date of passing of this resolution. Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to re-elect Mr. Jun Wu as an independent nonexecutive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to re-elect Mr. Yigang Shan as an executive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| KEROS THERAPEUTICS INC. | May 30, 2024 | To elect the three (3) nominees for director named below to hold office until the 2027 Annual Meeting of Stockholders: Jasbir Seehra Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| KKR REAL ESTATE FINANCE TRUST INC. | April 19, 2024 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| LANTRONIX INC. | November 7, 2023 | Election of Directors Jason Cohenour Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| LAZYDAYS HOLDINGS INC. | June 10, 2024 | Approval of an amendment to the 2018 Long-Term Incentive Plan to increase the number of authorized shares of common stock by 1,500,000. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| LAZYDAYS HOLDINGS INC. | June 10, 2024 | Approval, on an advisory basis, the compensation of our named executive officers Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| LEGACY HOUSING CORP. | December 1, 2023 | Election of Directors Curtis D. Hodgson Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| LIBERTY ENERGY INC. | April 16, 2024 | Approval of an amendment and restatement of the Company's long term incentive plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 6 funds |
| LIGHTBRIDGE CORP. | April 19, 2024 | Approval of an amendment to the Lightbridge Corporation 2020 Omnibus Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| LOVESAC CO. | June 11, 2024 | To approve Amendment No. 2 of the Second Amended and Restated 2017 Equity Incentive Plan that increases the number of shares reserved for issuance thereunder by 1,100,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| MACROGENICS INC. | May 21, 2024 | To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. Compensation |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| MAGELLAN MIDSTREAM PARTNERS LP | September 21, 2023 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of Magellan GP, LLC, the general partner of Magellan, that is based on or otherwise relates to the merger contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| MARATHON DIGITAL HOLDINGS INC. | June 27, 2024 | The approval of an amendment to our Amended and Restated 2018 Equity Incentive Plan (our "2018 Plan") to increase the number of shares of our common stock, par value $0.0001 per share, reserved under our 2018 Plan by 15,000,000, or from 30,000,000 shares to 45,000,000 shares. Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| MARRIOTT VACATIONS WORLDWIDE CORP. | May 10, 2024 | Approval of the Amended and Restated Marriott Vacations Worldwide Corporation 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 9 funds |
AGAINST 6 funds |
| MASTEC INC. | May 14, 2024 | Approval of a non-binding advisory resolution regarding the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 6 funds |
| MASTECH DIGITAL INC. | May 15, 2024 | Vote to approve the amendment and restatement of our Stock Incentive Plan originally effective as of October 1, 2008 and amended and restated effective as of May 14, 2014 (as amended through the date hereof, the "Plan"). Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| MERSANA THERAPEUTICS INC. | June 11, 2024 | Election of Class I Directors, each to serve until the 2027 Annual Meeting of Stockholders: Willard H. Dere, M.D. Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| MICROCHIP TECHNOLOGY INC. | August 22, 2023 | Proposal to approve an amendment and restatement of our 1994 International Employee Stock Purchase Plan to extend the term of the Plan by ten years to November 30, 2034. Compensation |
Board | For | AGAINST 14 funds |
FOR 11 funds |
| MICROCHIP TECHNOLOGY INC. | August 22, 2023 | Proposal to approve an amendment and restatement of our 2001 Employee Stock Purchase Plan to extend the term of the Plan by ten years to August 31, 2034. Compensation |
Board | For | AGAINST 14 funds |
FOR 11 funds |
| MUELLER INDUSTRIES INC. | September 26, 2023 | Approve the amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock by 150,000,000 shares. Capital Structure |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| NATURAL HEALTH TRENDS CORP. | May 14, 2024 | To approve, by advisory vote, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| NATURE'S SUNSHINE PRODUCTS INC. | May 1, 2024 | An advisory, non-binding resolution to approve the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| NEOGENOMICS INC. | May 23, 2024 | Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| NETGEAR INC. | May 30, 2024 | Proposal to approve, on a non-binding advisory basis, a resolution approving the compensation of our Named Executive Officers in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| NEVRO CORP. | May 23, 2024 | To approve, on a non-binding, advisory basis, the compensation of the named executive officers as disclosed in the Company's proxy statement in accordance with the compensation disclosure rules of the Securities and Exchange Commission Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| NEXPOINT RESIDENTIAL TRUST INC. | May 7, 2024 | Advisory Vote on Executive Compensation: to approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| NURIX THERAPEUTICS INC. | May 20, 2024 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| OCWEN FINANCIAL CORP. | May 28, 2024 | Approval, on an advisory basis, of the compensation of the named executive officers, as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| OIL-DRI CORPORATION OF AMERICA | December 13, 2023 | Approval of the Amended and Restated Oil-Dri Corporation of America 2006 Long Term Incentive Plan which, among other modifications, increases the number of shares authorized for issuance from 1,219,500 shares to 1,719,500 shares and increases the maximum individual grant size in any calendar year to 150,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ONE GROUP HOSPITALITY INC. | May 21, 2024 | Proposal to approve, by an advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ONE STOP SYSTEMS INC. | May 15, 2024 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| OPTIMIZERX CORP. | June 5, 2024 | Amendment to OptimizeRx Corporation 2021 Equity Incentive Plan to increase the aggregate number of shares of common stock available for awards by 1,950,000 shares to 4,450,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ORGANOGENESIS HOLDINGS INC. | June 20, 2024 | Approval of an amendment to our 2018 Equity Incentive Plan to increase the number of shares of Class A common stock reserved for issuance thereunder by 15,900,000 shares. Compensation |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| ORMAT TECHNOLOGIES INC. | May 8, 2024 | To approve an amendment and restatement of the Company's 2018 Incentive Compensation Plan to increase the total number of shares reserved thereunder. Compensation |
Board | For | AGAINST 9 funds |
FOR 7 funds |
| ORRSTOWN FINANCIAL SERVICES INC. | April 30, 2024 | Approve a non-binding advisory vote regarding the compensation paid to our Named Executive Officers ("Say-On-Pay"). Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| OUTSET MEDICAL INC. | May 29, 2024 | Advisory vote to approve 2023 named executive officer compensation Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| PAYSAFE LTD. | May 23, 2024 | To approve the re-election of Mr. Daniel Henson as a Class III director in accordance with our Bye-laws. Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 2 funds |
| PAYSAFE LTD. | May 23, 2024 | To approve the re-election of Mr. Eli Nagler as a Class III director in accordance with our Bye-laws. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 2 funds |
| PAYSAFE LTD. | May 23, 2024 | To approve the re-election of Mr. Peter Rutland as a Class III director in accordance with our Bye-laws. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 2 funds |
| PIEDMONT OFFICE REALTY TRUST INC. | May 7, 2024 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 1 fund |
| PJT PARTNERS INC. | June 20, 2024 | To elect the three nominees for Class III directors listed below, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders (Proposal 1): James Costos Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 2 funds |
| PLIANT THERAPEUTICS INC. | June 13, 2024 | To elect three class I directors named in the proxy statement to our Board of Directors Hoyoung HuhM.D., Ph.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
← Previous Page 2 of 3 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.